MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Functional Connectivity Differences Across Parkinson Disease Subtypes

    M. Campbell, C. Gratton, J. Koller, W. Shannon, C. Lessov-Schlaggar, S. Petersen, J. Perlmutter (St. Louis, MO, USA)

    Objective: The goals of this project were to 1) identify putative Parkinson disease (PD) clinical subtypes and 2) investigate resting-state functional connectivity differences between these…
  • 2017 International Congress

    Multicenter Validation of Disease- related Parkinson’s disease pattern with Resting State functional MRI

    K. Schindlbeck, A. Vo, Y. Ma, S. Peng, K. Poston, H. Hurtig, N. Dahodwala, D. Eidelberg (Manhasset, NY, USA)

    Objective: To validate Parkinson’s Disease-related network topography characterized with resting-state functional MRI (rs-fMRI) in two multicenter based cohorts of idiopathic Parkinson’s disease (IPD) patients.  Background:…
  • 2017 International Congress

    Olfactory Impairment in Parkinson’s Disease and White Matter Abnormalities in Central Olfactory Areas

    S. Sobhani, M. Aarabi (Tehran, Islamic Republic of Iran)

    Objective: To determine white matter abnormalities in PD patients with various degrees of olfactory impairment. Background: Neuroimaging results of PD brain based on diffusion tensor…
  • 2017 International Congress

    Analysis of related factors of occurrence of dementia in Parkinson’s disease using the application form of Parkinson’s disease provided by the specific diseases treatment research program of Ministry of Health, Labor and Welfare of Japan

    K. Konaka, M. Mihara, H. Mochizuki (Suita, Japan)

    Objective: Dementia has now been noticed as a significant non-motor symptom of Parkinson's disease (PD). We attempted to analyze the relation between the occurrence of…
  • 2017 International Congress

    Is cognitive decline similar among Parkinson’s disease motor sub-types? A prospective study examining changes over time in gait, balance and cognition

    T. Herman, L. Arie, S. Shema-Shiratzky, N. Giladi, J. Hausdorff (Tel Aviv, Israel)

    Objective: To investigate whether changes over time in cognitive and motor functions differ across the postural instability gait difficulty (PIGD) and tremor dominant (TD) motor…
  • 2017 International Congress

    Subjective visual vertical in patients with early Parkinson’s disease

    H.S. Kim, H. Lee, S. Chu (Kyunggi-do, Republic of Korea)

    Objective: To identify the changes of subjective visual vertical and any correlation between SVV and cognitive/motoric dysfunctions in Parkinson's disease. Background: Dysfunction of sensory system is…
  • 2017 International Congress

    Randomize study of occurrence of Parkinson’s syndrome in patients with rheumatoid arthritis.

    M. Mavlanov, S. Aslanova, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: We aimed to study an occurrence of Parkinson’s syndrome (PS), its relationship with duration of disease and age of patients with rheumatoid arthritis. Background:…
  • 2017 International Congress

    Parkinsonism through astrocytic GABA induce motor symptoms

    M.J. Lee, Y. Jang, J. Han, S.J. Kim, J. Kim, I. Ryu, X. Ju, M.J. Ryu, S.-Y. Choi, G.R. Kweon (Daejeon, Republic of Korea)

    Objective: Although reactive gliosis is a prominent feature of PD, its role in pathogenesis has remained elusive. Here we show that aberrantly synthesized GABA from reactive astrocytes tonically inhibits neighboring dopaminergic neuronal firing in SNpc, reducing dopamine production and release, leading to parkinsonian motor symptoms. Background: Parkinsonism is a clinical syndrome of movement abnormalities seen in Parkinson’s disease (PD), which has been attributed to cell-autonomous mechanism of doparminergic neuronal death in the substantia nigra pars compacta (SNpc). Methods: To identify the…
  • 2017 International Congress

    The diagnostic challenges of patients with possible multiple system atrophy

    M. Gultekin, R. Baydemir, M.F. Gol, M. Mirza (Kayseri, Turkey)

    Objective: The aim of the this study to review the diagnostic challenges of MSA and to evaluate the patients with different clinic types of MSA-…
  • 2017 International Congress

    Neurogenic Orthostatic Hypotension Burden of Illness Patient and Caregiver Survey: Impact of Symptoms

    D. Claassen, C. Adler, C. Gibbons, L.A. Hewitt (Nashville, TN, USA)

    Objective: To determine the impact of neurogenic orthostatic hypotension (nOH) on the quality of life (QoL) of patients with autonomic dysfunction and the burden on…
  • « Previous Page
  • 1
  • …
  • 273
  • 274
  • 275
  • 276
  • 277
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley